Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRIMARYS: Lanreotide Autogel as Primary Treatment in Acromegaly
NCT00690898Phase 3Completed
- Sponsor
- Ipsen
- Start
- May 2008
- Primary completion
- Feb 2012
- Modality
- Peptides
- Countries
- 9
01
Overview
A Phase 3 trial of lanreotide in acromegaly, sponsored by Ipsen. Started May 2008; status: completed.
02
Drugs
lanreotide
03
Conditions
acromegaly
Beyond the preview
Go deeper on NCT00690898.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00690898.